Evidence-based Complementary Oncology. Innovative Approaches to Optimize Standard Therapy Strategies

University of Cologne, Institute for Naturopathy, Joseph-Stelzmann-Strasse 9, 50931 Cologne, Germany.
In vivo (Athens, Greece) (Impact Factor: 0.97). 03/2007; 21(2):423-8.
Source: PubMed


Cancer diseases demand diagnostic and therapeutic measures with proven quality, safety and efficacy. The basis for evaluation is clinical studies representing levels I or II (randomized controlled trials (RCT) or epidemiological cohort studies) in accordance with recommendations of the Centre for Evidence-based Medicine, University of Oxford, UK Regarding these claims, surgery, chemo-, radio- and hormone therapy have emerged as the gold standard in the treatment of carcinomas. These therapies have proven their cancer destructive potencies and their curative feasibilities, dependent on the particular cancer entity and stage. Complementary therapies are recommended to support and optimize the scientifically-based cancer standard treatment. Complementary medicine is currently widely debated by the oncological community, because the required scientific proof of safety and effectiveness for most of the therapeutic approaches has not yet been definitively provided. In the past years, basic research and clinical evaluation of defined complementary therapeutic concepts in oncology have been intensified in an attempt to integrate these procedures into evidence-based medicine. Scientifically-based therapies of complementary medicine cannot replace the well studied conventional cancer-destructive therapies such as surgery, chemo-, radio- or hormone therapy. Accordingly, they are by no means "alternative therapies". Complementary approaches in oncology that are recommended as additional to standard cancer destructive therapies claim to optimize this therapy. A great body of data emerging from scientifically sound clinical trials prove that defined complementary procedures are beneficial for the patients.

18 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is no evidence that selenium supplements reduce side effects of chemotherapy, radiotherapy or the effects of surgery in cancer patients. Selenium is a mineral necessary for human health. Selenium acts against cell damage in the body and might help to alleviate the side effects of therapies in cancer patients, such as nausea, diarrhoea or the lymph retention in limbs. Selenium supplements are frequently used by cancer patients. This systematic review looked at studies providing selenium supplements to cancer patients and found no clear evidence that selenium supplements improve side effects of cancer therapy. No adverse effects were reported in the studies, but evidence of overdosing, all be it unintentional and selenium intoxication has occurred in several selenium users. More research is needed to find out which doses of selenium supplements can be reasonably used by cancer patients and whether selenium supplements can affect the side effects of cancer therapy.
    Cochrane database of systematic reviews (Online) 07/2006; 19(3):CD005037. DOI:10.1002/14651858.CD005037.pub2 · 6.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The interpretation of medical images by radiologists is primarily and fundamentally a subjective activity, but there are a number of clinical applications such as tumor imaging where quantitative imaging (QI) metrics (such as tumor growth rate) would be valuable to the patient's care. It is predicted that the subjective interpretive environment of the past will, over the next decade, evolve toward the increased use of quantitative metrics for evaluating patient health from images. The increasing sophistication and resolution of modern tomographic scanners promote the development of meaningful quantitative end points, determined from images which are in turn produced using well-controlled imaging protocols. For the QI environment to expand, medical physicists, physicians, other researchers and equipment vendors need to work collaboratively to develop the quantitative protocols for imaging, scanner calibrations, and robust analytical software that will lead to the routine inclusion of quantitative parameters in the diagnosis and therapeutic assessment of human health. Most importantly, quantitative metrics need to be developed which have genuine impact on patient diagnosis and welfare, and only then will QI techniques become integrated into the clinical environment.
    Medical Physics 12/2007; 34(11):4173-9. DOI:10.1118/1.2789501 · 2.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Spine surgery has been significantly influenced during the past 20 years by improvements in anaesthesia and radiology. This progress has also been promoted by technical developments in spinal instrumentation, mainly the introduction of pedicle screws and anterior support with cages. Both techniques allow correction and stabilisation methods that have had a major effect on tumour surgery. These advancements have allowed less experienced spine surgeons to perform tumour surgery, which may have a negative effect on the outcome. From our point of view, it should be required that tumour surgery be performed only in hospitals managing a certain number of tumours annually. For optimal results, en bloc resection and intralesional marginal resection in particular are highly demanding of the surgeon's technical skills and experience. Second and third operations complicate the intervention unnecessarily. Normally, R0 resection can not be achieved by a second or third revision. For this reason tumour surgery requires a standardised overall concept which must be suited to individual problems. This can be best decided in a tumour board meeting for choosing the options for adjuvant therapy. Only by such a coordinated effort may good mid- and long-term results be achieved.It must be pointed out that en bloc resection is the only surgical therapy that makes a curative approach possible. On the other hand it can also be demonstrated that by making extended, intralesional marginal resections as radical as possible, good mid-term results can be achieved. Here the adjuvant chemo- and radiotherapy play an important role.
    Der Chirurg 10/2008; 79(10):927-8, 930-6. · 0.57 Impact Factor
Show more


18 Reads
Available from